Molecular diagnosis of occult HCV and HBV infections

Future Virology

Volumn 2, Issue 5, 2007, Pages 451-465

  Michalak, Tomasz I ^a   Pham, Tram N Q ^a   Mulrooney Cousins, Patricia M ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

HBV; HCV; Hepadnaviruses; Hepatitis B; Hepatitis C; Hepatitis virus lymphotropism; Infection; Interferon; Molecular diagnosis; Occult hepatitis virus; Ribavirin; Viral persistence; Woodchuck viral hepatitis

Indexed keywords

ALPHA INTERFERON; RIBAVIRIN; VIRUS DNA; VIRUS RNA;

BLOOD SAMPLING; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; FEASIBILITY STUDY; GENE TARGETING; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNOCOMPETENT CELL; LABORATORY TEST; LIVER CELL; LIVER CELL CARCINOMA; NONHUMAN; NUCLEIC ACID AMPLIFICATION; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; REVIEW; SENSITIVITY ANALYSIS; VIRUS DETECTION; VIRUS GENOME; VIRUS IDENTIFICATION; VIRUS INFECTION; VIRUS REPLICATION;

HEPATITIS B VIRUS; HEPATITIS C VIRUS; MARMOTA MONAX;

EID: 34648827085     PISSN: 17460794     EISSN: None     Source Type: Journal    
DOI: 10.2217/17460794.2.5.451     Document Type: Review

References (82)

1. Seeff LB: Natural history of chronic hepatitis C. Hepatology 36, S35-S46 (2002).
2. Rehermann B, Nascimbeni M: Immunology of hepatitis B and hepatitis C virus infection. Nat. Rev. Immunol. 5, 215-229 (2005).
3. Fattovich G: Natural history and prognosis of hepatitis B. Semin. Liver Dis. 23, 47-58 (2003).
4. Mast EE, Hwang L-L, Seto DS et al.: Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection in infancy. J. Infect. Dis. 192, 1880-1889 (2005).
5. Mohan P, Colvin C, Glymph C et al.: Clinical spectrum and histopathologic features of chronic hepatitis C infection in children. J. Pediatr. 150, 168-174 (2007).
6. Pham TNQ, MacParland SA, Mulrooney PM, Cooksley H, Naoumov NV, Michalak TI: Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C. J. Virol. 78, 5867-5874 (2004).
7. Radkowski M, Gallegos-Orozco JF, Jablonska J et al.: Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C. Hepatology 41, 106-114 (2005).
8. Castillo I, Rodriguez-Inigo E, Lopez-Alcorocho JM, Pardo M, Bartolome J, Carreno V: Hepatitis C virus replicates in the liver of patients who have a sustained response to antiviral treatment. Clin. Infect. Dis. 43, 1277-1283 (2006).
9. Pham TNQ, MacParland SA, Coffin CS, Lee SS, Bursey FR, Michalak TI: Mitogen-induced upregulation of hepatitis C virus expression in human lymphoid cells. J. Gen. Virol. 86, 657-666 (2005).
10. Pham TNQ, Mulrooney-Cousins PM, Mercer SE et al.: Antagonistic expression of hepatitis C virus and α interferon in lymphoid cells during persistent occult infection. J. Viral Hepat. 14, 537-548 (2007).
11. Saleh M, Tibbs C, Koskinas J, Pereira L et al.: Hepatic and extrahepatic hepatitis C virus replication in relation to response to interferon therapy. Hepatology 20, 1399-1404 (1994).
12. Blackard JT, Kemmer N, Sherman KE: Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences. Hepatology 44, 15-22 (2006).
13. Pawlotsky JM: Use and interpretation of virological tests for hepatitis C. Hepatology 36, 565-573 (2002).
14. Strader DB, Wright T, Thomas DL, Seeff LB: Diagnosis, management and treatment of chronic hepatitis C. Hepatology 39, 1147-1171 (2004).
15. Chevaliez S, Pawlotsky JM: Hepatitis C virus serologic and virological tests and clinical diagnosis of HCV-related liver diease. Int. J. Med. Sci. 3, 35-40 (2006).
16. Katsoulidou A, Moschidis Z, Sypsa V et al.: Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with low viral load. Vox Sang. 92, 8-14 (2007).
17. Laskus T, Radkowski M, Jablonska J et al.: Human immunodeficiency virus facilitates infection/replication of hepatitis C virus in native human macrophages. Blood 103, 3854-3859 (2004).
18. Bartolomé J, López-Alsorocho JM, Castillo I et al.: Ultracentrifugation of serum samples allows detection of hepatitis C virus RNA in patients with occult hepatitis C. J. Virol. 81, 7710-7715 (2007).
19. Coffin CS, Mulrooney-Cousins PM, Lee SS, Michalak TI, Swain MG: Profound suppression of chronic hepatitis C following superinfection with hepatitis B virus. Liver Int. 27, 722-726 (2007).
20. Laskus T, Radkowski M, Wang LF, Vargas H, Rakela J: Lack of evidence for hepatitis G virus replication in the livers of patients coinfected with hepatitis C and G viruses. J. Virol. 71, 7804-7806 (1997).
21. MacParland SA, Pham TNQ, Gujar SA, Michalak TI: Infection and propagation of wild-type hepatitis C virus in human T lymphocytes in vitro. J. Gen. Virol. 87, 3577-3586 (2006).
22. Carriere M, Pene V, Breiman A et al.: A novel, sensitive, and specific RT-PCR technique for quantification of hepatitis C virus replication. J. Med. Virol. 79, 155-160 (2007).
23. Hoofnagle JH, Seeff LB, Bales ZB, Zimmerman HJ: Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen. N. Engl. J. Med. 298, 1379-1383 (1978).
24. Marusawa H, Uemoto S, Hijikata M et al.: Latent hepatitis virus infection in healthy individuals with antibodies to hepatitis B core antigen. Hepatology 31, 488-495 (2000).
25. Michalak TI, Pasquinelli C, Guilhot S, Chisari FV: Hepatitis B virus persistence after recovery from acute viral hepatitis. J. Clin. Invest. 93, 230-239 (1994).
26. Reherman B, Ferrari C, Pasquinelli C, Chisari FV: The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat. Med. 2, 1104-1108 (1996).
27. Michalak TI, Pardoe IU, Coffin CS et al.: Occult life-long persistence of infectious hepadnavirus and residual liver inflammation in woodchucks convalescent from acute viral hepatitis. Hepatology 29, 928-938 (1999).
28. Coffin CS, Pham TNQ, Mulrooney PM, Churchill ND, Michalak TI: Persistence of isolated antibodies to woodchuck hepatitis virus core antigen is indicative of occult virus infection. Hepatology 40, 1053-1061 (2004).
29. Hui C-K, Sun J, Au W-Y et al.: Occult hepatitis B virus infection in hematopoietic stem cell donors in a hepatitis B virus endemic area. J. Heptol. 42, 813-819 (2005).
30. Hui C-K, Bowden S, Zhang H-Y et al.: Comparison of real-time PCR assays for monitoring serum hepatitis B virus DNA levels during antiviral therapy. J. Clin. Microbiol. 44, 2983-2987 (2006).
31. Ronsin C, Pillet A, Bali C et al.: Evaluation of the COBAS AmpliPrep-total nucleic acid isolation-COBAS TaqMan hepatitis B virus (HBV) quantitative test and comparison to the VERSANT HBV DNA 3.0 Assay. J. Clin. Microbiol. 44, 1390-1399 (2006).
32. Murakami Y, Minami M, Daimon Y, Okanoue T: Hepatitis B virus DNA in liver, serum, and periperal blood mononuclear cells after the clearance of serum hepatitis B virus antigen. J. Med. Virol. 72, 203-214 (2004).
33. Michalak TI, Mulrooney PM, Coffin CS: Low doses of hepadnavirus induce infection of the lymphatic system that does not engage the liver. J. Virol. 78, 1730-1738 (2004).
34. Lew Y-Y, Michalak TI: In vitro and in vivo infectivity and pathogenicity of the lymphoid cell-derived woodchuck hepatitis virus. J. Virol. 75, 1770-1782 (2001).
35. Werle-Lapostolle B, Bowden S, Locarnini S et al.: Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. Gastroenterology 126, 1750-1758 (2004).
36. Tuttleman SJ, Pourcel C, Summers J: Formation of the pool of covalently closed circular DNA after in vitro infection of duck hepatocytes. Cell 47, 451-460 (1986).
37. Summers J, Smith PM, Horwich AL: Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification. J. Virol. 64, 2819-2824 (1990).
38. Braun RW, Reiser HC: Replication of human cytomegalovirus in human peripheral blood T cells. J. Virol. 60, 29-36 (1986).
39. Frenkel N, Schirmer EC, Katsafanas G, June CH: T cell activation is required for efficient replication of human herpesvirus 6. J. Virol. 64, 4598-4602 (1990).
40. Oldstone MB: Virus-lymphoid cell interactions. Proc. Natl Acad. Sci. USA 93, 12756-12758 (1996).
41. Ciurea A, Klenerman P, Hunziker L et al.: Persistence of lymphocytic chorlomeningitis virus at very low levels in immune mice. Proc. Natl Acad. Sci. USA 96, 11964-11969 (1999).
42. Michalak TI: Occult persistence and lymphotropism of hepadnaviral infection: insights from the woodchuck viral hepatitis model. Immunol. Rev. 174, 98-111 (2000).
43. Castillo I, Rodriguez-Inigo E, Bartolome J et al.: Hepatitis C virus replicates in peripheral blood mononuclear cells in patients with occult hepatitis C virus infection. Gut 54, 682-685 (2005).
44. Korba BE, Cote PJ, Wells FV et al.: Natural history of woodchuck hepatitis virus infections during the course of experimental viral infection: molecular virological features of the liver and lymphoid tissues. J. Virol. 63, 1360-1370 (1989).
45. Menne S, Cote PJ, Butler SD, Toshkov IA, Gerin JL, Tennant BC: Immunosuppression reactivates viral replication long after resolution of woodchuck hepatitis virus infection. Hepatology 45, 614-622 (2007).
46. Korba BE, Cote PJ, Gerin JL: Mitogen-induced replication of woodchuck hepatitis virus in cultured peripheral blood lymphocytes. Science 241, 1213-1216 (1988).
47. Coffin CS, Michalak TI: Persistence of infectious hepadnavirus in the offspring of woodchuck mothers recovered from viral hepatitis. J. Clin. Invest. 104, 203-212 (1999).
48. Taliani G, Badolato M, Lecce R et al.: Hepatitis C virus RNA in peripheral blood mononuclear cells: relation with response to interferon treatment. J. Med. Virol. 47, 16-22 (1995).
49. Hodgson PD, Michalak TI: Augmented hepatic interferon γ expression and T cell influx characterize acute hepatitis progressing to recovery and residual lifelong virus persistence in experimental adult woodchuck hepatitis virus infection. Hepatology 34, 1049-1059 (2001).
50. Bläckberg J, Kidd-Ljunggren K: Occult hepatitis B virus after acute self-limited infection persisting for 30 years without sequence variation. J. Hepatol. 33, 992-997 (2001).
51. Falcon V, Acosta-Rivero N, Shibayama M, et al.: Evidence of Hepatitis C virus replication in hepatocytes and peripheral blood mononuclear cells from patients negative for viral RNA in serum. Am. J. Inf. Dis. 1, 34-42 (2005).
52. Pardoe IU, Michalak TI: Detection of hepatitis B and woodchuck hepatitis viral DNA in plasma and mononuclear cells from heparinized blood by the polymerase chain reaction. J. Virol. Methods 51, 277-288 (1995).
53. Willems M, Moshage H, Nevens F, Fevery J, Yap SH: Plasma collected from heparinized blood is not suitable for HCV-RNA detection by conventional RT-PCR assay. J. Virol. Methods 42, 127-130 (1993).
54. Pham TNQ, Michalak TI: Occult hepatitis C virus persistence: identification and characteristics. Med. Lab. Obs. 38, 20-22 (2006).
55. Mulrooney PM, Michalak TI: Quantitative detection of hepadnavirus-infected lymphoid cells by in situ PCR combined with flow cytometry: implications for the study of occult virus persistence. J. Virol. 77, 970-979 (2003).
56. Muratori L, Gibellini D, Lenzi M et al.: Quantification of hepatitis C virus-infected peripheral blood mononuclear cells by in situ reverse transcriptase-polymerase chain reaction. Blood 88, 2768-2774 (1996).
57. Gibellini D, Zauli G, Re MC et al.: In situ polymerase chain reaction technique revealed by flow cytometry as a tool for gene detection. Anal. Biochem. 228, 252-258 (1995).
58. Castillo I, Pardo M, Bartolome J et al.: Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown. J. Infect. Dis. 189, 7-14 (2004).
59. Coffin CS, Pham TNQ, Urbanski SJ, Michalak TI, Lee SS: Persistent hepatic alterations in individuals with occult HCV infection following sustained virological response to antiviral therapy. J. Hepatol. 44, S196 (2006).
60. Quiroga JA, Llorente S. Castillo I et al.: Virus-specific T cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection. J. Med. Virol.. 78, 1190-1197 (2006).
61. Takaki A, Wiese M, Maertens G et al.: Cellular immune response persist, humoral responses decrease two decades after recovery from a single source outbreak of hepatitis C. Nat. Med. 6, 578-582 (2000).
62. Cramp ME, Carucc P, Chokshi S, Williams R, Naoumov NV: Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viremia. Gut 44, 424-429 (1999).
63. Mchalak TI: Immunology of hepatitis B virus. In: Hepatitis Prevention and Treatment, Colacino JM, Heinz BA (Eds). Birkhäuser Verlang, Basel, Switzerland, 87-105 (2004).
64. Thiers V, Nakajima E, Kresmsdorf D et al.: Sequences in blood samples negative for HBV serologic markers. Lancet 2, 1273-1276 (1988).
65. Tanaka Y, Esumi M, Shikata T: Persistence of hepatitis B virus DNA after serological clearance of hepatitis B virus. Liver 10, 6-10 (1990).
66. Cacciola I, Pollicino T, Squadrito G et al.: Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N. Engl. J. Med. 341, 22-26 (1999).
67. Paterlini P, Gerken G, Nakajima, E et al.: Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen. N. Engl. J. Med. 323, 80-85 (1990).
68. Blum HE, Liang TJ, Galun E, Wands JR: Persistence of hepatitis B viral DNA after serological recovery from hepatitis B virus infection. Hepatology 14, 56-63 (1991).
69. Penna A, Artini M, Cavaili A et al.: Longlasting memory T cell responses following sel-limited acute hepatitis. J. Clin. Invest. 98, 1185-1194 (1996).
70. Korba BE. Wells FC, Baldwin B et al.: Hepatocellular carcinoma in woodchucks hepatitis virus-infected woodchucks: presence of viral DNA in tumor tissue from chronic carriers and animals serologically recovered from acute infection. Hepatology 9, 461-470 (1989).
71. Gujar SA, Michalak II: Primary occult hepadnavirus infection induces both virus-specific and generalized T cell responses in the absence of virus-specific humoral immunity. Hepatology 44, 536A (2006).
72. Gujar SA, Michalak TI: Repeated exposure to small doses of hepadnavirus does not induce hepatitis but causes prominent virus-specific T cell responses in the absence of humoral immunity. J. Hepatol. 46, S157 (2007).
73. Pollicino T, Squadrito G, Cerenzia G et al.: Hepatitis B virus maintains its prooncogenic properties in the case of occult HBV infection. Gastroenterology 126, 102-110 (2004).
74. Liu C-J, Lo S-C, Kao J-H et al.: Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in Taiwan. J. Hepatol. 44, 39-46 (2006).
75. Raimondo G, Pollicino T, Cacciola I, Squadrito G: Occult hepatitis B virus infection. J. Hepatol. 46, 160-170 (2007).
76. Yuki N, Nagaoka T, Yamashiro M, Mochizuki K et al.: Long-term histologic and virologic outcomes of acute self-limited hepatitis B. Hepatology 37, 1172-1179 (2003).
77. Lok AS, Liang RH, Chiu EK, Wong KL, Chan TK, Todd D: Reactivation of hepatitis B virus replication in patients receiving cytotoxicity, therapy: report of a prospective study. Gastroenterology 100, 1432-1434 (1991).
78. Seth P, Alrajhi AA, Kagevi I et al.: Hepatitis B virus reactivation with clinical flare in allogenic stem cell transplants with chronic graft-versus-host disease. Bone Marrow Transpl. 30, 189-194 (2002).
79. Ghisetti V, Marzano A, Zambonii F et al.: Occult hepatitis B virus infection in HBsAg negative patients undergoing liver transplantation: clinical significance. Liver Transpl. 10, 356-362 (2004).
80. Chamorro AJ, Casado JL, Bellido D, Moreno S: Reactivation of hepatitis B in an HIV-infected patient with antibodies against hepatitis B core antigen as the only serological marker. Eur. J. Clin. Microbiol. Infect. Dis. 24, 492-494 (2005).
81. Hui C-K, Cheung WWW, Zhang H-Y et al.: Kinetics and risk of de novo hepatitis B infection In HBsAg-negative patients undergoinp cytotoxic chemotherapy. Gastroenterology, 131, 59-68 (2006).
82. Knöll A, Boehm S, Hahn J, Holler E. Jilg W: Long-term surveillance of hematopoietic stem cell recipients with resolved hepatitis B: high risk of viral reactivation even in a recipient with a vaccinated donor. J. Viral Hepat. 14, 478-483 (2007).